RBC Capital Cuts PT on Concordia Int'l (CXRX) to $27 Following Q2 REsults
Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.
RBC Capital lowers its price target on Outperform-rated Concordia International (Nasdaq: CXRX) from $33 down to $27 following Q2 results last week.
The firm commented,
Although we had recently revised our forecasts to reflect FX impact post-Brexit and weakness in the U.S. legacy business, our revisions were not significant enough and Concordia lowered its guidance beyond the Street's expectations. We believe the weakness Friday was overdone and would be buyers, as the shares now trade at a significant discount to peers (~30% '17E EV/EBITDA discount).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BMO Capital Raises Price Target on ManpowerGroup (MAN) Following 3Q Surprise
- Seaport Global Securities Upgrades Tutor Perini Corporation (TPC) to Buy
- Credit Suisse Downgrades Time Warner (TWX) to Neutral Following Takeover
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS View, Analyst PT Change
Related EntitiesRBC Capital
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!